Grifols SA

NASDAQ:GRFSUnited States

Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. The Company organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Its diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Its bio Supplies provides, mostly, biological products for non-therapeutic use.

Contact Information

Headquarters

Parque Empresarial Can Sant Joan Avinguda de la Generalitat, 152-158SANT CUGAT DEL VALLES, BAR, Spain 08174

Phone

---

Fax

---

Executives

Non-Executive Chairman of the Board, Other External Director

Thomas Glanzmann

Chief Executive Officer, Executive Director

Jose Ignacio Abia

Chief Financial Officer

Alfredo Arroyo Guerra

President - Plasma Procurement

Jordi Balsells Valls

President - Bio Supplies

Alberto Grifols Roura